WAGNER CHARLES F JR — SEC insider filings

SEC reporting owner CIK 1223348. 47 insider filings on record with FilingPulse; latest filed 2026-11-16.

Transaction summary — filings shown

Covers all 47 filings on record, filed 2021-02-05 to 2026-11-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
VERTEX PHARMACEUTICALS INC / MA (VRTX)EVP, CO & FO43—46 legs · 75,178 sh · $32,417,06742
TJX COMPANIES INC /DE/ (TJX)Director4——14

Insider filings — WAGNER CHARLES F JR

FiledFormIssuerReported transactionsSource
2026-11-164VERTEX PHARMACEUTICALS INC / MA (VRTX)Sale (S): 15,286 @ $547.87EDGAR
2026-06-114TJX COMPANIES INC /DE/ (TJX)Grant/award (A): 636.87 (derivative) @ $0 · Grant/award (A): 26.50 (derivative) @ $0 · Grant/award (A): 636.87 (derivative) @ $0 · Grant/award (A): 26.50 (derivative) @ $0EDGAR
2026-02-264VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 1,744 @ $485.11EDGAR
2026-02-194VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 7,365 @ $0 · Tax withholding (F): 2,294 @ $483.75EDGAR
2026-02-184VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 4,565 @ $487.76EDGAR
2026-02-124VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 3,045 @ $468.41EDGAR
2026-01-264VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 9,440 @ $0 · Grant/award (A): 4,160 @ $0EDGAR
2026-01-084VERTEX PHARMACEUTICALS INC / MA (VRTX)Option exercise (M): 9,532 @ $189.38 · Sale (S): 9,532 @ $461 · Option exercise (M): 9,532 (derivative) @ $0EDGAR
2025-12-054VERTEX PHARMACEUTICALS INC / MA (VRTX)Sale (S): 7,000 @ $451 · Sale (S): 7,000 @ $461EDGAR
2025-06-124TJX COMPANIES INC /DE/ (TJX)Grant/award (A): 793.40 (derivative) @ $0 · Grant/award (A): 20.60 (derivative) @ $0 · Grant/award (A): 793.40 (derivative) @ $0 · Grant/award (A): 20.60 (derivative) @ $0EDGAR
2025-03-124VERTEX PHARMACEUTICALS INC / MA (VRTX)Sale (S): 3,298 @ $500EDGAR
2025-02-284VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 4,962 @ $479.61EDGAR
2025-02-264VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 3,310 @ $483.28EDGAR
2025-02-194VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 2,293 @ $463.46EDGAR
2025-02-144VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 6,655 @ $0EDGAR
2025-02-124VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 2,649 @ $467.98EDGAR
2025-02-064VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 10,262 @ $0 · Grant/award (A): 7,114 @ $0EDGAR
2024-11-134VERTEX PHARMACEUTICALS INC / MA (VRTX)Sale (S): 3,000 @ $518.27EDGAR
2024-06-064TJX COMPANIES INC /DE/ (TJX)Grant/award (A): 944.55 (derivative) @ $0 · Grant/award (A): 9.35 (derivative) @ $0 · Grant/award (A): 944.55 (derivative) @ $0 · Grant/award (A): 9.35 (derivative) @ $0EDGAR
2024-06-054VERTEX PHARMACEUTICALS INC / MA (VRTX)Sale (S): 3,250 @ $460EDGAR
2024-05-304VERTEX PHARMACEUTICALS INC / MA (VRTX)Sale (S): 3,250 @ $454.79EDGAR
2024-02-274VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 3,309 @ $431.79EDGAR
2024-02-214VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 3,750 @ $424.01 · Tax withholding (F): 2,812 @ $420.58EDGAR
2024-02-134VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 2,607 @ $422.74EDGAR
2024-02-084VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 5,814 @ $0 · Grant/award (A): 9,440 @ $0 · Grant/award (A): 7,114 @ $0EDGAR
2024-01-044VERTEX PHARMACEUTICALS INC / MA (VRTX)Sale (S): 3,000 @ $405EDGAR
2023-11-214VERTEX PHARMACEUTICALS INC / MA (VRTX)Sale (S): 3,000 @ $349.88EDGAR
2023-09-224TJX COMPANIES INC /DE/ (TJX)Grant/award (A): 721.35 (derivative) @ $0 · Grant/award (A): 721.35 (derivative) @ $0EDGAR
2023-03-284VERTEX PHARMACEUTICALS INC / MA (VRTX)Sale (S): 1,768 @ $305.38EDGAR
2023-03-214VERTEX PHARMACEUTICALS INC / MA (VRTX)Sale (S): 360 @ $294.52 · Sale (S): 784 @ $295.43 · Sale (S): 240 @ $296.30 · Sale (S): 360 @ $298.09 · Sale (S): 240 @ $299.58 · Sale (S): 16 @ $301.13EDGAR
2023-03-144VERTEX PHARMACEUTICALS INC / MA (VRTX)Sale (S): 361 @ $286.64 · Sale (S): 515 @ $287.83 · Sale (S): 327 @ $288.91 · Sale (S): 30 @ $289.44 · Sale (S): 541 @ $291.47 · Sale (S): 185 @ $292.68 · +8 moreEDGAR
2023-02-284VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 3,308 @ $289.12EDGAR
2023-02-224VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 3,750 @ $292.85EDGAR
2023-02-144VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 2,707 @ $294.33 · Tax withholding (F): 4,992 @ $298.26EDGAR
2023-02-034VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 10,324 @ $0 · Grant/award (A): 10,262 @ $0 · Grant/award (A): 9,440 @ $0EDGAR
2022-05-044VERTEX PHARMACEUTICALS INC / MA (VRTX)Sale (S): 20 @ $254.87 · Sale (S): 100 @ $257.18 · Sale (S): 60 @ $258.21 · Sale (S): 80 @ $259.45 · Sale (S): 48 @ $261.15 · Sale (S): 32 @ $262.06 · +1 moreEDGAR
2022-05-034VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 547 @ $276.17EDGAR
2022-04-054VERTEX PHARMACEUTICALS INC / MA (VRTX)Sale (S): 300 @ $261.42 · Sale (S): 381 @ $263.67 · Sale (S): 1,142 @ $265.06 · Sale (S): 536 @ $265.95 · Sale (S): 223 @ $266.68EDGAR
2022-03-214VERTEX PHARMACEUTICALS INC / MA (VRTX)Sale (S): 3,110 @ $250.13 · Sale (S): 61 @ $251.05EDGAR
2022-02-284VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 2,189 @ $227.86EDGAR
2022-02-224VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 3,439 @ $232.51EDGAR
2022-02-144VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 2,434 @ $237.74EDGAR
2022-02-034VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 3,698 @ $0 · Grant/award (A): 11,628 @ $0 · Grant/award (A): 10,262 @ $0 · Sale (S): 2,944 @ $250.07EDGAR
2021-05-054VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 547 @ $217.21EDGAR
2021-02-264VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 547 @ $217.57EDGAR
2021-02-124VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 2,365 @ $214.16EDGAR
2021-02-054VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 10,324 @ $0 · Grant/award (A): 11,627 @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1223348 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs